Austin D. Laroche

FDA Outlines "Plausible Mechanism" Approval Pathway For Personalized Therapies, But Significant Questions Remain

Stem Cell Litigation Update: FDA Won The Latest Battle, But The Future Of HCT/P Enforcement Remains Unclear

Top 10 Takeaways From FDA's Revised Quality System Requirements For Medical Devices

FDA Proposed Rule Would Harmonize U.S. Quality System Requirements For Medical Devices With International Standard

CMS Finalizes Repeal Of Medicare "Breakthrough" Device Coverage Rule, Pledges To Invite Further Industry Input